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CASE REPORT
Eggerthella lenta bacteraemia in endometrial adenocarcinoma — a case report
from Pakistan
Tazeen Fatima, Rumina Hasan, Samia Tariq

Abstract
We report a case of Eggerthella lenta bacteraemia. An
elderly
lady
with
metastasised
endometrial
adenocarcinoma presented with complaints of fever
nausea vomiting and abdominal pain. CT scan of the
abdomen showed enlarged liver with multiple metastatic
lesions raising suspicion of small-bowel obstruction. Due
to multiple comorbid conditions, surgery was
contraindicated and she was treated empirically with
meropenem and vancomycin. Blood culture received on
admission grew Eggerthela lenta.
Keywords: Eggerthela lenta, Bacteremia, Endometrial
adenocarcinoma.
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Introduction
Eggerthella lenta, an anaerobic, non-sporulating,
nonmotile, Gram-positive rod is an emerging pathogen. It
is particularly associated with infections in
immunocompromised population.1 The infectious
burden of Eggerthella lenta (previously known as
Eubacteria species) is underreported due to challenges in
phenotypic identification. E. lenta has been identified as
the causative pathogen in various conditions including
sinusitis, appendicitis, pyomyositis, skin abscesses, and
spondylodiscitis but the pathogenicity and virulence is
partially understood. We report a case of disseminated
anaerobic infection with Eggerthella lenta in a patient
with diagnosed endometrial carcinoma

Case Report
A 53-year-old female from middle socioeconomic
background and a known case of poorly differentiated
endometrial adenocarcinoma with metastasis to lungs,
bones, and peritoneum was admitted at the Aga Khan
University Hospital on April 12, 2017. She complained of
fever, abdominal pain, weakness, nausea and vomiting
since the previous day. She had undergone modified
radical hysterectomy with bilateral salpingoAga Khan University Hospital, Karachi, Pakistan.
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oophorectomy and bilateral percutaneous nephrostomy
in 2016, and primary total hip replacement in 2017.
On admission, the patient's temperature was 39.5°C,
blood pressure 112/74 mmHg, pulse 98/min, and
respiratory rate was 20 breaths/min. Abdominal
examination revealed diffused tenderness while CT scan
of the abdomen showed enlarged liver with multiple
peritoneal metastatic lesions raising suspicion of smallbowel obstruction. Laboratory investigations showed Hb
at 7.8 g/dL, leukocyte count at 16.7×109/L, platelet count
at 660 ×109/L, C-reactive protein (CRP) level at 19.38
mg/dL and creatinine at 1.2 mg/dL. A urine sample and
two sets of blood samples were sent for culture. Since
surgery was contraindicated due to multiple
comorbidities, the patient was managed on empiric
antibiotic therapy including intravenous Meropenem 1
gram 8 hourly and intravenous Vancomycin 1 gram 12
hourly.
After three days of incubation, the anaerobic blood
culture in BACTEC (Becton Dickinson) system grew grampositive bacilli. Anaerobic subculture yielded a growth of
catalase positive, tiny pinpointed translucent colonies on
Blood agar plate. Pleomorphic gram-positive bacilli were
observed on Gram stain of the growing colonies. Grampositive bacilli were consequently identified as
Eggerthella lenta by API 20 Anaerobe (bioMérieux).
Susceptibility was tested by performing minimum
inhibitory concentration (MIC) using E-Strip on 5% sheep
blood agar and according to Clinical and Laboratory
Standards Institute (CLSI) breakpoints.2 Etest results
demonstrated sensitivity to Amoxicillin/Clavulanate
(MIC= 0.047 μg/mL) and Imepenem (MIC=0.015) but
resistance to metronidazole (MIC > 256 μg/mL).

Discussion
E. lenta of the Coriobacteriaceae family is an anaerobic,
non-spore-forming, gram-positive bacillus first isolated
from human faeces in 1935 by Eggerth,1 the whole
genomic sequence was defined in 2009.3 The spectrum of
disease caused by this organism is vague and has been
most commonly associated with intra-abdominal
infections exhibiting symptoms of diarrhoea vomiting and
abdominal pain. It has, however, also been isolated from
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various other clinical specimens including blood,
abscesses and wounds aspirates.4 Risk factors associated
with E. lenta infections include malignancies, end-stage
renal disease, diabetes, pelvic inflammatory disease,
decubitus ulcers, abscesses, genitourinary tract infections
and gastrointestinal diseases like ulcerative colitis, Crohn's
disease, pancreatic and diverticular abscess, and
appendicitis. Isolation of Eggerthella lenta from blood
culture should not be considered as contamination
keeping in view high (36-34%) mortality associated with
it.5 However one view is that the approach to always treat
E.lenta bacteraemia may lead to overuse of antibiotics but
at the same time ignoring and not treating might have
grave consequences. Patients with E.lenta require apt and
immediate evaluation of source that may include skin and
soft tissues, obstetric-genitourinary tract or intraabdominal infections and source control. Though clinical
guidelines for treatment of E.lenta infections are not
established, previous case reports have reported effective
treatment with a broad-spectrum β-lactam or
combination therapy with metronidazole plus a β-lactam.6
An informed verbal consent was obtained on telephone
for writing the case report. In this case, the patient
presented with high grade fever, nausea, vomiting,
abdominal cramps and leukocytosis. Risk factors included
endometrial malignancy. The most likely explanation for
her bacteraemia was translocation of the organism from
the gastrointestinal tract due to disturbed mucosal
integrity caused by intestinal obstruction. In view of her
multiple comorbidities and a high surgery risk, she was
provided with comfort care, along with IV meropenem.
The patient, however, succumbed to bacteraemia after 10
days of admission.

Conclusion
We report a patient with a potentially fatal bacteraemia
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with E. lenta. In summary, Eggerthella species can lead to
invasive infections in immunocompromised hosts
particularly in patients with malignancy and complicated
abdominal infections. In view of this case report and
previously reported cases, the occurrence of grampositive bacillus in blood should never be disregarded
given its high mortality; it warrants thorough
investigation to explore and control the source and avoid
complications. More work is required to comprehend the
pathogenicity, clinical progression of infections, and
antimicrobial susceptibility pattern.
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